0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Комментарии 0 Поделились 791 Просмотры 0 предпросмотр
-
Cell Therapy Market Grows Globally with Advancements in Regenerative Medicine"Executive Summary Cell Therapy Market : CAGR Value The global cell therapy market size was valued at USD 21.16 million in 2024 and is expected to reach USD 86.23 million by 2032, at a CAGR of 19.20% during the forecast period Today’s cut-throat era calls for businesses to be equipped with knowhow of the major happenings of the...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Dendritic Cell Cancer Vaccine Market Opportunities in Precision MedicinePharmaceutical companies are expanding their oncology pipelines to include dendritic cell vaccine therapies. Continuous research is leading to the discovery of new therapeutic targets. These advancements are strengthening the market. The Dendritic Cell Cancer Vaccine Market is gaining significant attention in the global oncology landscape as immunotherapy continues to revolutionize cancer...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Комментарии 0 Поделились 369 Просмотры 0 предпросмотр
Спонсоры
Спонсоры